FNY Managed Accounts’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
BB
FNY Managed Accounts's NVAX Position: Q1 2018 in Review
FNY Managed Accounts opened a new position in Novavax (NVAX) in Q1 2018: 25 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #525 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in NVAX as recently as Q1 2014.
FNY Managed Accounts first reported a position in NVAX in Q1 2014 and has held it in 2 quarters since. The position peaked at $50K in Q1 2014. 151 funds tracked by Wall St. Rank hold NVAX as of Q1 2018.
- FNY Managed Accounts held 25 shares of Novavax worth $1K as of Q1 2018.
- Novavax was a new FNY Managed Accounts position in Q1 2018.
- Novavax made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #525 holding.
- FNY Managed Accounts first reported a position in Novavax in Q1 2014 and has held it in 2 quarters since.
- FNY Managed Accounts's Novavax position peaked at $50K in Q1 2014.
- 151 funds tracked by Wall St. Rank held Novavax as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.